Orlando Regional Medical Center is an 808-bed tertiary hospital in downtown Orlando, Florida designed by HKS, Inc. and Walter P Moore. It is the flagship of the Orlando Health system.

There are 808 beds in Orlando Regional Medical Center.

During the past decade, Orlando Regional Medical Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 20 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orlando Regional Medical Center" #1 sponsor was "Boston Scientific Corporation" with 7 trials, followed by "Abbott Medical Devices" with 4 trials sponsored, "Major Extremity Trauma Research Consortium" with 3 trials sponsored, "Cook Group Incorporated" with 2 trials sponsored and "Cumberland Pharmaceuticals" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Regional Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "United States Department of Defense" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "Baxter Healthcare Corporation" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Regional Medical Center" are "Coronary Artery Disease" (6 trials), "Heart Failure" (5 trials), "Pulmonary Embolism" (3 trials), "Bradycardia" (2 trials) and "Burns" (2 trials). Many other conditions were trialed in "Orlando Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Orlando Regional Medical Center" are "Device" (21 trials), "Drug" (12 trials), "Procedure" (6 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vonoprazan" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials), "ACURATE Prime™ Transfemoral TAVR System XL" (1 trials) and "ACURATE neo2™ Transfemoral TAVR System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Regional Medical Center" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Orlando Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Orlando Regional Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 15 trials that are defined as “Not Applicable".